<p>Dr. Phil Bonomi, from Rush University, describes the generations of EGFR inhibitors beginning with Gefitinib (Iressa).</p>

Dr. Phil Bonomi, from Rush University, describes the generations of EGFR inhibitors beginning with Gefitinib (Iressa).

Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

Share Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors

Sign up to save your podcasts

Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors

Dr. Philip Bonomi: Gefitinib and Later Generations of EGFR Inhibitors

More shows like GRACEcast Lung Cancer Video

GRACEcast Head and Neck Cancer Audio

GRACEcast Radiation Oncology Audio

GRACEcast Radiation Oncology Video

GRACEcast Pancreatic Cancer Audio

GRACEcast Pancreatic Cancer Video

GRACEcast Cancer 101 Audio

GRACEcast Bladder Cancer Video

GRACEcast Head and Neck Cancer Video NEW

GRACEcast Cancer 101 Video